Nekotorye prognosticheskie faktory pri sovremennoy terapii khronicheskogo limfoleykoza
- Authors: Byalik TE1, Grivtsova LY.1, Karseladze AI1, Zagoskina TP2, Bessmel'tsev SS3, Volkova MA4
-
Affiliations:
- РОНЦ им.Н.Н.Блохина РАМН, Москва
- НИИ Гематологии и переливания крови, Киров
- Российский НИИ гематологии и трансфузиологии, Санкт-Петербург
- РОНЦ им. Н.Н.Блохина РАМН, Москва
- Issue: Vol 8, No 4 (2006)
- Pages: 16-19
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/26636
- ID: 26636
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
T E Byalik
РОНЦ им.Н.Н.Блохина РАМН, Москва
L Yu Grivtsova
РОНЦ им.Н.Н.Блохина РАМН, Москва
A I Karseladze
РОНЦ им.Н.Н.Блохина РАМН, Москва
T P Zagoskina
НИИ Гематологии и переливания крови, Киров
S S Bessmel'tsev
Российский НИИ гематологии и трансфузиологии, Санкт-Петербург
M A Volkova
РОНЦ им. Н.Н.Блохина РАМН, Москва
References
- Schulz H, Klein S, Rehwald U et al. Phase 2 study of combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia. Blood 2002; 100: 3115-20.
- Keating M, Plunkett W, Х Brain S et. al. Combination therapy in CLL. Leukemia 2000, Program and abstract book. p. 26, abstr. S25.
- Calligalis-Cappio F. Biology of chronic lymphocytic leukemia. Reu Clin Exp Heamatol 2000; 4 (1): 5-22.
- Byrd J. A new twist for CD38 antigen expression in CLL. Blood 2005; 105 (8): 3002-3.
- Damle R.N, Wasil T, Fais F et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94 (6): 1840-7.
- Hamblin T.J, Orchard J.A, Ibbotson R.E et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99 (3): 1023-9.
- Lin K, Sherrington P.D, Dennis M et al. Relatioship between p53 dysfunction, CD38 expression, and Ig VH mutation in chronic lymphocytic leukemia. Blood 2002; 100 (4): 1404-9.
- Juliusson G, Oscier D.G, Fitcher M et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990; 323: 720-4.
- Dohner H, Stilgenbauer S, Benner A et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-6.
- Goorha S, Glenn M.J, Drozd-Borysiuk E, Chen Z. A set of commercially available fluorescent in - situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia. Genet Med 2004; 6: 48-53.